422
Views
16
CrossRef citations to date
0
Altmetric
Full-Length Research Paper

Circulating levels of chemokines in psoriasis

, , , , &
Pages 57-60 | Received 28 Jan 2014, Accepted 17 Jul 2014, Published online: 13 Aug 2014

References

  • Nestle, F. O., D. H. Kaplan, and J. Barker. 2009. Psoriasis. N. Engl. J. Med. 361: 496–509
  • Griffiths, C. E., and J. N. Barker. 2007. Pathogenesis and clinical features of psoriasis. Lancet. 370: 263–271
  • Cai, Y., C. Fleming, and J. Yan. 2012. New insights of T cells in the pathogenesis of psoriasis. Cell. Mol. Immunol. 9: 302–309
  • Byrne, F. R., A. Winters, D. Brankow, et al. 2009. An antibody to IP-10 is a potent antagonist of cell migration in vitro and in vivo and does not affect disease in several animal models of inflammation. Autoimmunity. 42: 171–182
  • Rottman, J. B., T. L. Smith, K. G. Ganley, et al. 2001. Potential role of the chemokine receptors CXCR3, CCR4, and the integrin alphaEbeta7 in the pathogenesis of psoriasis vulgaris. Lab. Invest. 81: 335–347
  • Chen, S. C., M. de Groot, D. Kinsley, et al. 2010. Expression of chemokine receptor CXCR3 by lymphocytes and plasmacytoid dendritic cells in human psoriatic lesions. Arch. Dermatol. Res. 302: 113–123
  • Gunther, C., N. Carballido-Perrig, S. Kaesler, et al. 2012. CXCL16 and CXCR6 are upregulated in psoriasis and mediate cutaneous recruitment of human CD8+ T cells. J. Invest. Dermatol. 132: 626–634
  • Oh, S. T., A. Schramme, W. Tilgen, et al. 2009. Overexpression of CXCL16 in lesional psoriatic skin. Dermatoendocrinology. 1: 114–118
  • Antonelli, A., P. Fallahi, A. Delle Sedie, et al. 2008. High values of alpha (CXCL10) and beta (CCL2) circulating chemokines in patients with psoriatic arthritis, in presence or absence of autoimmune thyroiditis. Autoimmunity. 41: 537–542
  • Ekman, A. K., G. Sigurdardottir, M. Carlstrom, et al. 2013. Systemically elevated Th1-, Th2- and Th17-associated chemokines in psoriasis vulgaris before and after ultraviolet B treatment. Acta. Derm. Venereol. 93: 527–531
  • Horn, E. J., K. M. Fox, V. Patel, et al. 2007. Are patients with psoriasis undertreated? Results of National Psoriasis Foundation survey. J. Am. Acad. Dermatol. 57: 957–962
  • Yeung, H., J. Takeshita, N. N. Mehta, et al. 2013. Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatol. 149: 1173–1179
  • Johnston, A., S. Arnadottir, J. E. Gudjonsson, et al. 2008. Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation. Br. J. Dermatol. 159: 342–350
  • Rosenblum, J. M., N. Shimoda, A. D. Schenk, et al. 2010. CXC chemokine ligand (CXCL) 9 and CXCL10 are antagonistic costimulation molecules during the priming of alloreactive T cell effectors. J. Immunol. 184: 3450–3460
  • Wuest, T., J. Farber, A. Luster, and D. J. Carr. 2006. CD4+ T cell migration into the cornea is reduced in CXCL9 deficient but not CXCL10 deficient mice following herpes simplex virus type 1 infection. Cell. Immunol. 243: 83–89
  • Groom, J. R., and A. D. Luster. 2011. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol. Cell. Biol. 89: 207–215
  • Aeberli, D., M. Seitz, P. Juni, and P. M. Villiger. 2005. Increase of peripheral CXCR3 positive T lymphocytes upon treatment of RA patients with TNF-alpha inhibitors. Rheumatology (Oxford) 44: 172–175
  • Kunkel, E. J., J. Boisvert, K. Murphy, et al. 2002. Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes. Am. J. Pathol. 160: 347–355
  • Loos, T., L. Dekeyzer, S. Struyf, et al. 2006. TLR ligands and cytokines induce CXCR3 ligands in endothelial cells: enhanced CXCL9 in autoimmune arthritis. Lab. Invest. 86: 902–916
  • Call, D. R., J. A. Nemzek, S. J. Ebong, et al. 2001. Ratio of local to systemic chemokine concentrations regulates neutrophil recruitment. Am. J. Pathol. 158: 715–721
  • Flier, J., D. M. Boorsma, P. J. van Beek, et al. 2001. Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. J. Pathol. 194: 398–405
  • Goebeler, M., A. Toksoy, U. Spandau, et al. 1998. The C-X-C chemokine Mig is highly expressed in the papillae of psoriatic lesions. J. Pathol. 184: 89–95
  • Linkov, F., Y. Gu, A. A. Arslan, et al. 2009. Reliability of tumor markers, chemokines, and metastasis-related molecules in serum. Eur. Cytokine. Netw. 20: 21–26

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.